Marcel Muelbaier

2.3k total citations
15 papers, 828 citations indexed

About

Marcel Muelbaier is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Marcel Muelbaier has authored 15 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Marcel Muelbaier's work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Marcel Muelbaier is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Marcel Muelbaier collaborates with scholars based in Germany, United Kingdom and United States. Marcel Muelbaier's co-authors include Marcus Bantscheff, John D. Harling, Thilo Werner, Han Dai, Cyrille S. Kounde, Edward W. Tate, Douglas W. Thomson, M.D. Rackham, Maria M. Shchepinova and Paul F. Fitzpatrick and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Chemical Communications.

In The Last Decade

Marcel Muelbaier

15 papers receiving 812 citations

Peers

Marcel Muelbaier
Jakob Fuhrmann United States
Benedict‐Tilman Berger Germany
Stephanie Blencke Germany
Kenneth M. Comess United States
James D. Vasta United States
Daniel Scheibe United States
Arwin Aban United States
Eric Okerberg United States
Elena Casale Italy
Mark Watson Canada
Jakob Fuhrmann United States
Marcel Muelbaier
Citations per year, relative to Marcel Muelbaier Marcel Muelbaier (= 1×) peers Jakob Fuhrmann

Countries citing papers authored by Marcel Muelbaier

Since Specialization
Citations

This map shows the geographic impact of Marcel Muelbaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Muelbaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Muelbaier more than expected).

Fields of papers citing papers by Marcel Muelbaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Muelbaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Muelbaier. The network helps show where Marcel Muelbaier may publish in the future.

Co-authorship network of co-authors of Marcel Muelbaier

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Muelbaier. A scholar is included among the top collaborators of Marcel Muelbaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Muelbaier. Marcel Muelbaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Muelbaier, Marcel, et al.. (2025). The Chemistry and Biology of the Tetrodotoxin Natural Product Family. Angewandte Chemie International Edition. 64(35). e202502404–e202502404. 1 indexed citations
2.
Stacey, Peter, Xiao Qing Lewell, Agnieszka Konopacka, et al.. (2021). A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications. SLAS DISCOVERY. 26(7). 885–895. 5 indexed citations
3.
Law, Robert P., João Nunes, Chun‐wa Chung, et al.. (2021). Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs. Angewandte Chemie International Edition. 60(43). 23327–23334. 85 indexed citations
4.
Law, Robert P., João Nunes, Chun‐wa Chung, et al.. (2021). Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs. Angewandte Chemie. 133(43). 23515–23522. 4 indexed citations
5.
Kounde, Cyrille S., Maria M. Shchepinova, Marcel Muelbaier, et al.. (2020). A caged E3 ligase ligand for PROTAC-mediated protein degradation with light. Chemical Communications. 56(41). 5532–5535. 107 indexed citations
6.
Tinworth, Christopher P., Zuni I. Bassi, Marcel Muelbaier, et al.. (2019). PROTAC-Mediated Degradation of Bruton’s Tyrosine Kinase Is Inhibited by Covalent Binding. ACS Chemical Biology. 14(3). 342–347. 134 indexed citations
7.
Eberl, H. Christian, Thilo Werner, Friedrich Reinhard, et al.. (2019). Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells. Scientific Reports. 9(1). 14159–14159. 33 indexed citations
8.
Thomson, Douglas W., Daniel Poeckel, Nico Zinn, et al.. (2019). Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor. ACS Medicinal Chemistry Letters. 10(5). 780–785. 66 indexed citations
9.
Johansson, Henrik, Chun‐wa Chung, Sandra Kümper, et al.. (2019). Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP. Journal of the American Chemical Society. 141(6). 2703–2712. 90 indexed citations
10.
Thomson, Douglas W., Marcus Bantscheff, R. Edward Benson, et al.. (2017). Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines. Journal of Medicinal Chemistry. 60(13). 5455–5471. 24 indexed citations
11.
Werner, Thilo, et al.. (2017). Differential Kinobeads Profiling for Target Identification of Irreversible Kinase Inhibitors. ACS Chemical Biology. 12(10). 2515–2521. 23 indexed citations
12.
Becher, Isabelle, Thilo Werner, Carola Doce, et al.. (2016). Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat. Nature Chemical Biology. 12(11). 908–910. 165 indexed citations
13.
Rutkowska, Anna, Douglas W. Thomson, Johanna Vappiani, et al.. (2016). A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level. ACS Chemical Biology. 11(9). 2541–2550. 67 indexed citations
14.
Joberty, Gérard, Markus Böesche, Jack A. Brown, et al.. (2016). Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics. ACS Chemical Biology. 11(7). 2002–2010. 23 indexed citations
15.
Ficht, Simon, Marcel Muelbaier, & Athanassios Giannis. (2001). ChemInform Abstract: Development of New and Efficient Polymer‐Supported Hypervalent Iodine Reagents.. ChemInform. 32(37). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakob Fuhrmann Breakdown of academic impact, for papers by Benedict‐Tilman Berger Breakdown of academic impact, for papers by Stephanie Blencke Breakdown of academic impact, for papers by Kenneth M. Comess Breakdown of academic impact, for papers by James D. Vasta Breakdown of academic impact, for papers by Daniel Scheibe Breakdown of academic impact, for papers by Arwin Aban Breakdown of academic impact, for papers by Eric Okerberg Breakdown of academic impact, for papers by Elena Casale Breakdown of academic impact, for papers by Mark Watson
Rankless by CCL
2026